AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

Recruitingn/aAges 50 Years - 70 YearsMaleRegina Elena Cancer Institute
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study aims to investigate alterations in the bladder microbiome in adult men with bladder cancer, healthy men, and men with benign urinary disease

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria (Bladder Cancer Patients): * Diagnosis of bladder cancer * Negative urine culture * Histological confirmation of urothelial carcinoma * Patients undergoing radical cystectomy Exclusion Criteria: * Presence of other neoplasias * History of previous BCG therapy * Use of indwelling catheter * Active antibiotic treatment with two months prior to participation * History of sexual transmitted diseases * Presence of chronic intestinal inflammation * Previous neoadyuvant therapy Inclusion Criteria Controls No-Pathologic/Healthy): \- Controls will be collected from men within the specified age range. Eligible controls may be drawn from the institution's personnel attending the occupational medicine department or in service in the Institute. Exclusion Criteria: * Diabetes * Chronic Kidney Disease * Cardiac disease * Hepatic disease Inclusion Criteria(Benign Urinary Disease) -To ensure that alterations in the microbiome observed in bladder cancer patients are unique to this condition, an additional group with benign urinary diseases will be included in the analysis. This group will encompass individuals with renal cysts, benign prostatic obstruction, ureteropelvic or ureteral obstruction undergoing surgical therapy. Exclusion Criteria: * NA
๐Ÿ’Š

What it tests

  • Investigating differences in the bladder microbiome
๐Ÿ“

Where

1 site
"Regina Elena" National Cancer Institute
Rome, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy